342 related articles for article (PubMed ID: 33593354)
41. m6A modification on the fate of colorectal cancer: functions and mechanisms of cell proliferation and tumorigenesis.
Jiang X; Jin Z; Yang Y; Zheng X; Chen S; Wang S; Zhang X; Qu N
Front Oncol; 2023; 13():1162300. PubMed ID: 37152066
[TBL] [Abstract][Full Text] [Related]
42. N6-methyladenine RNA modification and cancer.
Yang J; Chen J; Fei X; Wang X; Wang K
Oncol Lett; 2020 Aug; 20(2):1504-1512. PubMed ID: 32724392
[TBL] [Abstract][Full Text] [Related]
43. Expression profiles and prognostic significance of RNA N6-methyladenosine-related genes in patients with hepatocellular carcinoma: evidence from independent datasets.
Zhou Y; Yin Z; Hou B; Yu M; Chen R; Jin H; Jian Z
Cancer Manag Res; 2019; 11():3921-3931. PubMed ID: 31118805
[No Abstract] [Full Text] [Related]
44. Targeting YTHDF2 inhibits tumorigenesis of diffuse large B-cell lymphoma through ACER2-mediated ceramide catabolism.
Chen X; Lu T; Ding M; Cai Y; Yu Z; Zhou X; Wang X
J Adv Res; 2023 Oct; ():. PubMed ID: 37865189
[TBL] [Abstract][Full Text] [Related]
45. N6-Methyladenosine RNA Modification in Inflammation: Roles, Mechanisms, and Applications.
Luo J; Xu T; Sun K
Front Cell Dev Biol; 2021; 9():670711. PubMed ID: 34150765
[TBL] [Abstract][Full Text] [Related]
46. The role of IGF2BP2, an m6A reader gene, in human metabolic diseases and cancers.
Wang J; Chen L; Qiang P
Cancer Cell Int; 2021 Feb; 21(1):99. PubMed ID: 33568150
[TBL] [Abstract][Full Text] [Related]
47. Emerging function of N6-methyladenosine in cancer.
Hong K
Oncol Lett; 2018 Nov; 16(5):5519-5524. PubMed ID: 30344705
[TBL] [Abstract][Full Text] [Related]
48. YTHDF2-mediated regulations bifurcate BHPF-induced programmed cell deaths.
Lin J; Zhan G; Liu J; Maimaitiyiming Y; Deng Z; Li B; Su K; Chen J; Sun S; Zheng W; Yu X; He F; Cheng X; Wang L; Shen B; Yao Z; Yang X; Zhang J; He W; Wu H; Naranmandura H; Chang KJ; Min J; Ma J; Björklund M; Xu PF; Wang F; Hsu CH
Natl Sci Rev; 2023 Dec; 10(12):nwad227. PubMed ID: 38152479
[TBL] [Abstract][Full Text] [Related]
49. Decoding m
Sun L; Chen X; Zhu S; Wang J; Diao S; Liu J; Xu J; Li X; Sun Y; Huang C; Meng X; Lv X; Li J
Genes Dis; 2024 Mar; 11(2):711-726. PubMed ID: 37692496
[TBL] [Abstract][Full Text] [Related]
50. The Emerging Role of m6A Modification in Endocrine Cancer.
Ji X; Wang Z; Sun W; Zhang H
Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831377
[TBL] [Abstract][Full Text] [Related]
51. YTHDF2/3 Are Required for Somatic Reprogramming through Different RNA Deadenylation Pathways.
Liu J; Gao M; Xu S; Chen Y; Wu K; Liu H; Wang J; Yang X; Wang J; Liu W; Bao X; Chen J
Cell Rep; 2020 Sep; 32(10):108120. PubMed ID: 32905781
[TBL] [Abstract][Full Text] [Related]
52. Regulation of N6-Methyladenosine in the Differentiation of Cancer Stem Cells and Their Fate.
Xu Y; Liu J; Chen WJ; Ye QQ; Chen WT; Li CL; Wu HT
Front Cell Dev Biol; 2020; 8():561703. PubMed ID: 33072746
[TBL] [Abstract][Full Text] [Related]
53. METTL14 promotes prostate tumorigenesis by inhibiting THBS1 via an m6A-YTHDF2-dependent mechanism.
Wang Y; Chen J; Gao WQ; Yang R
Cell Death Discov; 2022 Mar; 8(1):143. PubMed ID: 35354789
[TBL] [Abstract][Full Text] [Related]
54. Role of m6A methyltransferase component VIRMA in multiple human cancers (Review).
Zhu W; Wang JZ; Wei JF; Lu C
Cancer Cell Int; 2021 Mar; 21(1):172. PubMed ID: 33731118
[TBL] [Abstract][Full Text] [Related]
55. The emerging role of RNA N6-methyladenosine methylation in breast cancer.
Zheng F; Du F; Zhao J; Wang X; Si Y; Jin P; Qian H; Xu B; Yuan P
Biomark Res; 2021 May; 9(1):39. PubMed ID: 34044876
[TBL] [Abstract][Full Text] [Related]
56. YT521-B homology domain family proteins as N6-methyladenosine readers in tumors.
Yang H; Chiang C; Luo Q; Chen C; Huang J; Zhu L; Zheng D
Front Genet; 2022; 13():934223. PubMed ID: 36017491
[TBL] [Abstract][Full Text] [Related]
57. M6A RNA Methylation Regulator HNRNPC Contributes to Tumorigenesis and Predicts Prognosis in Glioblastoma Multiforme.
Wang LC; Chen SH; Shen XL; Li DC; Liu HY; Ji YL; Li M; Yu K; Yang H; Chen JJ; Qin CZ; Luo MM; Lin QX; Lv QL
Front Oncol; 2020; 10():536875. PubMed ID: 33134160
[TBL] [Abstract][Full Text] [Related]
58. Dysregulated m6A-Related Regulators Are Associated With Tumor Metastasis and Poor Prognosis in Osteosarcoma.
Li J; Rao B; Yang J; Liu L; Huang M; Liu X; Cui G; Li C; Han Q; Yang H; Cui X; Sun R
Front Oncol; 2020; 10():769. PubMed ID: 32582536
[No Abstract] [Full Text] [Related]
59. N6-Methyladenosine in RNA and DNA: An Epitranscriptomic and Epigenetic Player Implicated in Determination of Stem Cell Fate.
Ji P; Wang X; Xie N; Li Y
Stem Cells Int; 2018; 2018():3256524. PubMed ID: 30405719
[TBL] [Abstract][Full Text] [Related]
60. Emerging roles of RNA methylation in gastrointestinal cancers.
Xie S; Chen W; Chen K; Chang Y; Yang F; Lin A; Shu Q; Zhou T; Yan X
Cancer Cell Int; 2020 Dec; 20(1):585. PubMed ID: 33372610
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
